Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 2/20 | 0.55 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.54 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.54 |
| ▸ | CYP17A1 | P05093 | 2/20 | 0.54 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31663517 | 0.87 | XDH (0.52) | XDHCYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL8665465 | 0.83 | MCL1 (0.51) | XDHCYP11B2CYP11B1CYP19A1KDM4E | |
| SCHEMBL29293022 | 0.83 | XDH (0.42) | XDHCYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL29292888 | 0.83 | XDH (0.42) | XDHCYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL31663569 | 0.82 | CYP11B2 (0.47) | XDHCYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL29292889 | 0.81 | XDH (0.47) | XDHCYP11B2CYP11B1CYP19A1CNR1 | |
| SCHEMBL29293021 | 0.81 | XDH (0.47) | XDHCYP11B2CYP11B1CYP19A1CNR1 | |
| SCHEMBL6439562 | 0.79 | CYP11B2 (0.56) | CYP11B2CYP11B1CYP17A1CYP19A1KDM4E | |
| SCHEMBL31663540 | 0.79 | CNR1 (0.50) | XDHCYP11B2CYP11B1CYP17A1CYP19A1 | |
| SCHEMBL14856915 | 0.78 | ESR2 (0.55) | CYP11B2CYP11B1CNR1CNR2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX INC (JP) | 2025-11-20 | — | — | US | disclosed |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2025-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250359476-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | CRY2, SLCO1B3, NDUFV3 | XDH 1719/4885CYP11B2 1221/4885CYP11B1 1903/4885 |
| US-12369492-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, SLCO1B3, NDUFV3 | XDH 1719/4885CYP11B2 1221/4885CYP11B1 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.